Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelini Ventures Global Intelligence Hub, leveraging its proprietary AI-powered platform and global network of advisors to accelerate the growth of innovative ventures in healthcare Established partnerships with Enterprise Singapore and AI Singapore to […]
Day One Biopharmaceuticals to Acquire Mersana Therapeutics GlobeNewswire November 13, 2025 Agreement with Day One Biopharmaceuticals provides for upfront consideration of $25.00 per share in cash, plus potential contingent value rights cash payments of up to an aggregate of $30.25 per share, for aggregate deal value of up to approximately $285 million Closing is expected
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former The AZEK Company Investors Who Received James Hardie PLC (NYSE: JHX) Shares in Connection with James Hardie's Acquisition of AZEK in July 2025 to Contact the Firm GlobeNewswire November 13, 2025 SAN FRANCISCO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Girard Sharp LLP, a national investment and securities
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Former Ansys, Inc. Investors Who Received Synopsys, Inc. (NASDAQ: SNPS) Shares in Connection with Synopsys's Acquisition of Ansys in July 2025 to Contact the Firm GlobeNewswire November 13, 2025 SAN FRANCISCO, Nov. 13, 2025 (GLOBE NEWSWIRE) — Girard Sharp LLP, a national investment, securities, and consumer class action
JOYY to Announce Third Quarter 2025 Financial Results on November 19, 2025 GlobeNewswire November 13, 2025 SINGAPORE, Nov. 13, 2025 (GLOBE NEWSWIRE) — JOYY Inc. (NASDAQ: JOYY) (“JOYY” or the “Company”), a global technology company, today announced that it plans to release its third quarter 2025 financial results after the U.S. market closes on November
Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases GlobeNewswire November 13, 2025 Acquisition expands Day One's portfolio with novel antibody-drug conjugate (ADC) emiltatug ledadotin (Emi-Le) Emi-Le has demonstrated early anti-tumor activity in an ongoing Phase 1 study for adenoid cystic carcinoma type-1
RecycLiCo to Engage Global Investors and Industry Leaders at Benchmark Week 2025 GlobeNewswire November 13, 2025 DELTA, British Columbia, Nov. 13, 2025 (GLOBE NEWSWIRE) — RecycLiCo Battery Materials Inc. (“RecycLiCo” or the “Company”) (TSX.V: AMY | OTCQB: AMYZF |FSE: ID4), a critical minerals refining and lithium-ion battery upcycling company, today announced that Interim Chief Executive
Hitachi Solutions and Radware To Launch Radware Cloud Application Protection Service to Defend Against Evolving Web DDoS Attacks Using AI AI-powered algorithms automatically detect and accurately mitigate burst attacks and HTTPS flood attacks, helping prevent service and business disruptions. GlobeNewswire November 13, 2025 TOKYO and MAHWAH, N.J., Nov. 13, 2025 (GLOBE NEWSWIRE) — Hitachi Solutions,
BrainsWay Receives FDA Clearance of Deep TMS(TM) as Adjunct Therapy for Major Depressive Disorder (MDD) in Adolescents Aged 15 to 21 Deep TMS(TM) becomes first and only TMS device cleared in treatment of patients aged 15 to 86 suffering from depression GlobeNewswire November 13, 2025 BURLINGTON, Mass. and JERUSALEM, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE)
Angelini Ventures to support Singapore biotech ecosystem development with first Asia office GlobeNewswire November 13, 2025 Launched its first Asia office to support biotech and healthtech innovation and collaboration within the region The Asia office will house the Angelini Ventures Global Intelligence Hub, leveraging its proprietary AI-powered platform and global network of advisors to accelerate